Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespan

The traditional view of chronic obstructive pulmonary disease (COPD) as a self-inflicted disease caused by tobacco smoking in genetically susceptible individuals has been challenged by recent research findings. COPD can instead be understood as the potential end result of the accumulation of gene–environment interactions encountered by an individual over the life course. Integration of a time axis in pathogenic models of COPD is necessary because the biological responses to and clinical consequences of different exposures might vary according to both the age of an individual at which a given gene–environment interaction occurs and the cumulative history of previous gene–environment interactions.
Puedes leer el artículo completo aquí: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00555-5/fulltext#seccestitle10
Autores: Alvar Agusti, Prof. Erik Melén, Dawn L DeMeo, Robab Breyer-Kohansal, Prof. Rosa Faner.
Noticias relacionadas

Human senescent fibroblasts trigger fibrogenic reaction in the lungs of immunodeficient mice
A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as «Aging (Albany NY)» and «Aging-US» by Web of Science) Volume 15, Issue 14, entitled, «Human senescent fibroblasts trigger progressive lung fibrosis in mice.»

COPD and multimorbidity: recognising and addressing a syndemic occurrence
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer.

Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression
The role of the immune response in the pathogenesis of idiopathic pulmonary fibrosis (IPF) remains controversial.
Más artículos
EPOC
- Leonardo M Fabbri et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence
- Singh D, Criner GJ, Agustí A et al. Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
- Alvar Agusti, M.D., Ph.D. – Biologics for COPD — Finally Here
- D. Pellegrino, S. Casas-Recasens, R. Faner, P. Palange, A. Agusti. When GETomics meets aging and exercise in COPD
- Alvar Agustí et al.- GOLD 2023: What’s New, Doc?
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en Canva Pro el 21/02/2023 libre de derechos para difusión en blog.